Use of ezetimibe results in more patients reaching lipid targets without side effects

Abstract

In patients referred to the lipid clinic (typically because of side effects or failure to reach targets on other lipid-lowering therapy) treatment with ezetimibe significantly increased proportion of those achieving their target lipid levels. This was not accompanied by significant side effects.

Keywords

• Diabetes
• ezetimibe
• lipid targets
• monotherapy